Javascript must be enabled to continue!
Frequency of prolactin pulsatile release in normal men and in agonadal patients is neither coupled to LH release nor influenced by androgen modulation
View through CrossRef
OBJECTIVE We wished to examine and characterize the prolactin pulsatile secretory pattern In both normal and agonadal males in order to assess whether there was any concordance with LH secretion.DESIGN Patients were sampled every 5 minutes for 12 hours.PATIENTS We studied five normal and four agonadal men, the latter group before and on testosterone enanthate (TE) (200 mg l.m. every 15 days) treatment.MEASUREMENTS Prolactin and luteinizing hormone plasma levels were determined using commercial RIA systems. Pulse detection was performed using the DETECT program and the degree of concordance between luteinizing hormone and prolactin was established computing the specific concordance Index.RESULTS We demonstrated the presence of a frequent PRL secretory pattern in normal men (22.8±1.8 peaks/12h; mean±SEM) and in agonadal patients, both in basal conditions and during testosterone treatment (20.5±2.8 and 18±1.6 peaks/12h, respectively). The testosterone treatment in agonadal men significantly reduced luteinlzing hormone pulse frequency (baseline: 27.5±2, testosterone administration: 18.1±3 peaks/12h, P <0.01) but did not affect pulsatile prolactin release. Using a 10 and 15 minute sampling protocol, we observed that prolactin pulse frequency significantly decreased (P <0.01) and was similar to the frequencies estimated In previous reports. When lutelnizing hormone and prolactin time series were studied to evaluate the possible presence of a specific concordance (SC) between the secretory events of the two hormones, no significant degree of concomitancy was observed neither using the specific concordance index or the cross‐correlation analysis.CONCLUSONS This report demonstrates (a) the presence of frequent pulsatile release of prolactin in both controls and agonadal patients (baseline and on testosterone enanthate), (b) the use of an appropriate sampling Interval (5 minutes) to unmask the prolactin pulsatile release, (c) that in men, lutelnizing hormone secretory events are not temporally linked to prolactin secretion, and (d) that androgens, even if reducing luteinlzing hormone pulse frequency in agonadal patients, do not significantly affect prolactin pulsatile secretion, suggesting that testosterone and its metabolites do not affect lactotroph activity.
Title: Frequency of prolactin pulsatile release in normal men and in agonadal patients is neither coupled to LH release nor influenced by androgen modulation
Description:
OBJECTIVE We wished to examine and characterize the prolactin pulsatile secretory pattern In both normal and agonadal males in order to assess whether there was any concordance with LH secretion.
DESIGN Patients were sampled every 5 minutes for 12 hours.
PATIENTS We studied five normal and four agonadal men, the latter group before and on testosterone enanthate (TE) (200 mg l.
m.
every 15 days) treatment.
MEASUREMENTS Prolactin and luteinizing hormone plasma levels were determined using commercial RIA systems.
Pulse detection was performed using the DETECT program and the degree of concordance between luteinizing hormone and prolactin was established computing the specific concordance Index.
RESULTS We demonstrated the presence of a frequent PRL secretory pattern in normal men (22.
8±1.
8 peaks/12h; mean±SEM) and in agonadal patients, both in basal conditions and during testosterone treatment (20.
5±2.
8 and 18±1.
6 peaks/12h, respectively).
The testosterone treatment in agonadal men significantly reduced luteinlzing hormone pulse frequency (baseline: 27.
5±2, testosterone administration: 18.
1±3 peaks/12h, P <0.
01) but did not affect pulsatile prolactin release.
Using a 10 and 15 minute sampling protocol, we observed that prolactin pulse frequency significantly decreased (P <0.
01) and was similar to the frequencies estimated In previous reports.
When lutelnizing hormone and prolactin time series were studied to evaluate the possible presence of a specific concordance (SC) between the secretory events of the two hormones, no significant degree of concomitancy was observed neither using the specific concordance index or the cross‐correlation analysis.
CONCLUSONS This report demonstrates (a) the presence of frequent pulsatile release of prolactin in both controls and agonadal patients (baseline and on testosterone enanthate), (b) the use of an appropriate sampling Interval (5 minutes) to unmask the prolactin pulsatile release, (c) that in men, lutelnizing hormone secretory events are not temporally linked to prolactin secretion, and (d) that androgens, even if reducing luteinlzing hormone pulse frequency in agonadal patients, do not significantly affect prolactin pulsatile secretion, suggesting that testosterone and its metabolites do not affect lactotroph activity.
Related Results
Abstract A6: Androgen receptor-mediated transcription is reprogrammed after hormone depletion
Abstract A6: Androgen receptor-mediated transcription is reprogrammed after hormone depletion
Abstract
Androgen receptor (AR) is a ligand-induced transcription factor, which binds to thousands of genomic loci and activates a cell-type specific gene expression...
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
On Flores Island, do "ape-men" still exist? https://www.sapiens.org/biology/flores-island-ape-men/
<span style="font-size:11pt"><span style="background:#f9f9f4"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><spa...
Prolactin Monitoring in Community Patients Receiving Long-Acting Injectables
Prolactin Monitoring in Community Patients Receiving Long-Acting Injectables
Aims:
The purpose of this audit was to ensure that patients who are receiving long acting injectables of antipsychotic medication are having their prolactin mon...
Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones
Opioidergic regulation of prolactin secretion during pregnancy: role of ovarian hormones
Abstract
We have recently demonstrated the existence of a neuromodulatory regulation of prolactin secretion by the opioid system showing a paradoxical opioid-indu...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Prolactin binding by testes of unilaterally cryptorchid rats: the effect of hCG, testosterone, prolactin and orchiopexy
Prolactin binding by testes of unilaterally cryptorchid rats: the effect of hCG, testosterone, prolactin and orchiopexy
Abstract.
The effect of unilateral cryptorchidism on prolactin binding to the testes was studied in the rat. Cryptorchidism was rendered surgically for 3 weeks and 3, 6 and 9 weeks...
Role of Protein Kinases in the Prolactin‐Induced Intracellular Calcium Rise in Chinese Hamster Ovary Cells Expressing the Prolactin Receptor
Role of Protein Kinases in the Prolactin‐Induced Intracellular Calcium Rise in Chinese Hamster Ovary Cells Expressing the Prolactin Receptor
AbstractThere is still only limited understanding of the early steps of prolactin signal transduction in target cells. It has been shown that prolactin actions are associated with ...
Prolactin Hormone
Prolactin Hormone
Prolactin (PRL) is mainly produced by pituitary lactotrophs and is tonically inhibited by the hypothalamus by the neurotransmitter dopamine. The discovery of multiple extra pituita...

